ImmunityBio Inc (IBRX)
3.055
+0.18
(+6.45%)
USD |
NASDAQ |
Dec 16, 16:00
3.08
+0.02
(+0.82%)
After-Hours: 20:00
ImmunityBio Profit Margin (Quarterly): -1.40K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Q32 Bio Inc | -- |
| HCA Healthcare Inc | 7.26% |
| Biomarin Pharmaceutical Inc | 14.22% |
| Incyte Corp | 9.36% |
| Insmed Inc | -236.0% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -136.9% |
| Return on Invested Capital | -963.1% |
| Operating Margin (Quarterly) | -1.31K% |
| Return on Net Operating Assets | -267.4% |